https://www.live-feeds.com/feed/peptides-get-a-green-lightContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/peptides-get-a-green-lighthttps://www.live-feeds.com/feed/peptides-get-a-green-light#u172009Tue, 03 Nov 2026 11:41:16 +0000The U.S. health department has permitted the broad, temporary sale of six unapproved peptides, using a regulatory shortcut led by RFK Jr. that bypasses standard FDA review processes. This policy shift makes the popular substances more widely available to the public, setting off a wave of market demand while drawing intense pushback from regulatory scientists. Critics point to numerous safety warnings surrounding the products, raising questions about oversight standards and public health risks as distribution begins.Why it mattersThe decision marks a significant deviation from traditional drug